Exit Readiness Checklist · Home Health Agency

Is Your Home Health Agency Ready to Sell?

Use this step-by-step checklist to clean up compliance records, strengthen your financials, and maximize your valuation before going to market — so buyers compete for your Medicare-certified agency instead of negotiating you down.

Selling a home health agency is not like selling a typical small business. Buyers — whether PE-backed roll-up platforms or individual operators using SBA financing — will scrutinize your CMS certification history, billing compliance, payor mix, staff credentialing, and referral source relationships before making an offer. A single open RAC audit, a lapsed state license, or heavy owner dependency can shrink your multiple from 6x to 3.5x or kill a deal entirely. The good news: most of the factors that drive valuation are within your control if you start preparing 12–24 months before you plan to go to market. This checklist walks you through every phase of exit readiness, organized by timeline, so you can close at the highest possible multiple with the fewest surprises in due diligence.

Get Your Free Home Health Agency Exit Score

5 Things to Do Immediately

  • 1Order your agency's CMS Home Health Compare profile and star rating report today — know exactly what buyers will see on day one before you speak to a single buyer
  • 2Call your billing company or compliance vendor this week and request a summary of your Medicare claim denial rate and any open overpayment demands — this is the single highest-risk area in any home health acquisition
  • 3Print your last 12 months of P&L statements and circle every expense that has a personal or owner benefit component — this is the foundation of your normalized EBITDA and it directly determines your asking price
  • 4Confirm with your state health department that your home health license is current, in good standing, and not up for renewal in the next 18 months — a lapse during a transaction is a deal-killer
  • 5Ask your director of nursing or top clinical supervisor today if they would stay with the agency under new ownership — their answer tells you exactly how much transition risk a buyer will price into their offer

Phase 1: Compliance and Licensure Foundation

18–24 months before going to market

Commission a third-party billing compliance audit

highCan protect or restore 0.5x–1.5x EBITDA multiple by eliminating buyer discount for unknown compliance risk

Engage a healthcare compliance firm to audit the last 3 years of Medicare and Medicaid claims. Identify claim denial rates, overpayment exposure, and any patterns that could trigger a RAC or ZPIC audit. Resolve identified issues before a buyer discovers them. Buyers will conduct their own audit in due diligence — yours should find problems first.

Verify and document all state licenses, Medicare/Medicaid certifications, and accreditations

highPrevents deal-killing delays; licensure gaps can cause buyers to walk or demand 10–20% price reductions

Confirm your Medicare certification, state home health license, and any CHAP or Joint Commission accreditation are current, in good standing, and not due for renewal during a likely deal window. Understand whether your state license is transferable or requires a new application in a change-of-ownership scenario. Note any certificate of need (CON) restrictions in your state.

Compile full CMS survey history and resolve open plans of correction

highClean survey history supports the upper end of the 3.5x–6x multiple range

Gather all CMS Conditions of Participation survey results from the last 3–5 years. If any deficiencies exist, ensure plans of correction are fully documented and closed. Buyers will pull your agency's CMS survey history on day one. Unresolved deficiencies or a pattern of repeat citations signals operational risk and will suppress your multiple.

Review OASIS documentation practices and PDGM coding accuracy

highAccurate coding can improve EBITDA margin by 2–5%, directly increasing enterprise value

Audit your OASIS assessment documentation and PDGM functional and clinical grouping codes for accuracy. Systematic undercoding leaves revenue on the table; overcoding creates overpayment liability. Correcting either before sale improves both your trailing EBITDA and your compliance posture.

Confirm EVV system compliance across all visit types

mediumEliminates a common buyer discount of 5–10% for technology or compliance gaps

Verify your Electronic Visit Verification system is fully implemented, integrated with your billing platform, and generating compliant records for all in-home visits. EVV non-compliance is a Medicaid reimbursement risk and a red flag for buyers evaluating your technology infrastructure.

Phase 2: Financial Clean-Up and Normalization

12–18 months before going to market

Separate all personal and owner expenses from business financials

highProperly documented add-backs can increase stated EBITDA by 15–30%, directly multiplying enterprise value

Remove owner personal expenses — vehicles, travel, health insurance, family salaries, and other add-backs — from business profit and loss statements. Work with your accountant to prepare normalized EBITDA statements that clearly document every add-back with supporting documentation. Buyers and SBA lenders will scrutinize every line item.

Prepare 3 years of clean P&Ls, tax returns, and a trailing 12-month income statement

highClean, reconciled financials reduce buyer risk perception and support asking price without discount

Ensure your business tax returns match your internal P&Ls and that any discrepancies are explainable in writing. Prepare a trailing 12-month (TTM) income statement updated monthly. SBA-financed buyers require 3 years of business tax returns and a current year P&L — incomplete records are a common deal-stopper.

Build a detailed payor mix report segmented by revenue source

highDemonstrating payor diversification can add 0.25x–0.75x to your EBITDA multiple

Create a monthly revenue breakdown showing Medicare, Medicaid, managed care, VA, and private pay as percentages of total revenue. Buyers will model revenue concentration risk — agencies with 80%+ government payor dependency and no managed care or private pay contracts will be discounted relative to diversified agencies.

Document referral source relationships and admission volume by source

highInstitutionalized referral relationships reduce buyer transition risk and support full asking price

Compile a 24-month history of admissions by referral source — hospitals, physician practices, SNFs, and other partners. Quantify the volume and revenue each source generates. Confirm that key referral relationships are institutional and not entirely dependent on your personal relationships as the owner.

Prepare accounts receivable aging and analyze DSO trends

mediumImproving DSO from 60+ days to under 45 days can recover $50K–$200K in working capital at close

Clean up outstanding Medicare and Medicaid claims beyond 90 days. Analyze days sales outstanding (DSO) over the trailing 12 months. Excessive AR aging signals billing inefficiencies and will reduce the working capital peg in a deal, effectively lowering your net proceeds.

Phase 3: Operational and Clinical Documentation

9–15 months before going to market

Build and document clinical and operational standard operating procedures

highDocumented operations reduce owner-dependency discount, supporting multiples at the higher end of the 3.5x–6x range

Create written SOPs for patient intake, OASIS assessments, care plan development, visit scheduling, billing workflows, and quality assurance processes. Buyers need to know the agency can operate without you. Undocumented processes that live in your head create transition risk and suppress offers.

Create an organizational chart with defined clinical and administrative roles

highNon-owner management team is one of the top value drivers buyers cite for justifying 5x–6x multiples

Document your full organizational structure including director of nursing, clinical supervisors, billing manager, and scheduling coordinator. Identify which roles are filled by qualified W-2 employees versus contractors or owner-performed functions. Buyers want to see a leadership team that will survive ownership transition.

Execute employment agreements with key clinical staff

highKey employee agreements reduce post-close attrition risk and support full earnout payment if structured into the deal

Ensure your director of nursing, lead physical therapists, and billing manager have written employment agreements with reasonable notice periods. Some buyers will require key employee retention bonuses funded at close. Retaining credentialed clinical staff post-acquisition is one of the top pain points buyers face in this industry.

Prepare a current patient census report with payor and clinical detail

highStrong census documentation with 60+ active patients can accelerate buyer interest and support pricing at 5x+

Build a report showing all active patients with admission date, payor source, primary diagnosis, assigned disciplines, and average weekly visits. Buyers will use this to model forward revenue and evaluate census stability. Agencies with 50–100+ active patients and long average length of service command stronger offers.

Document and quantify your CMS star ratings and clinical outcomes

medium4+ star ratings are a documented differentiator that buyers factor into premium pricing and strategic fit

Compile your agency's current Home Health Compare star ratings, HHCAHPS patient satisfaction scores, and hospitalization and rehospitalization rates versus national benchmarks. Agencies with 4–5 star ratings have a measurable competitive advantage in value-based care contracting and referral development.

Phase 4: Legal and Transaction Preparation

6–12 months before going to market

Engage a healthcare M&A attorney to understand CHOW process and deal structure options

highProper legal structuring prevents deal collapse during CHOW and protects your net proceeds from unnecessary holdbacks

The CMS change-of-ownership process is not optional — it runs concurrently with or after closing and can take 60–180 days depending on the deal structure and state. A healthcare M&A attorney can help you understand whether an asset or stock sale is preferable, how anti-kickback and Stark Law apply to your referral relationships, and how to structure holdbacks and earnouts tied to CHOW approval.

Identify and resolve any outstanding litigation, HIPAA breaches, or employment claims

highUndisclosed liabilities are the most common cause of post-LOI price reductions of 10–25%

Disclose and resolve any pending employment disputes, HIPAA breach notifications, or civil monetary penalty proceedings before going to market. Buyers will conduct background searches on the agency and ownership — surprises discovered in due diligence give buyers leverage to reprice or terminate.

Understand your state's Medicaid enrollment transfer requirements

highProactive planning prevents buyers from using enrollment gaps as justification for price reductions

In many states, Medicaid provider agreements do not automatically transfer in an asset sale and must be re-enrolled under the new owner. This can result in a revenue gap of 30–90 days post-close. Understanding this timeline lets you negotiate deal terms — including working capital, earnouts, and closing adjustments — that protect your proceeds.

Select a healthcare-focused business broker or M&A advisor

highExperienced healthcare advisors routinely achieve 10–20% higher exit prices than seller-represented or generalist-brokered transactions

Engage a broker or advisor with documented experience closing home health agency transactions in the lower middle market. They should understand Medicare CHOW, SBA financing for healthcare businesses, and how to position your payor mix and star ratings to strategic and PE buyers. A generic business broker without healthcare experience will undervalue your agency and mismanage the due diligence process.

Set valuation expectations based on current EBITDA multiples and your specific profile

mediumRealistic pricing aligned with market multiples reduces time on market and improves close rates

Understand that home health agencies in the $1M–$5M revenue range typically sell for 3.5x–6x EBITDA, with the spread driven by compliance history, star ratings, payor mix, census size, and management depth. Work with your advisor to build a realistic valuation range before you engage buyers — sellers with unrealistic expectations lose credibility and deal momentum.

See What Your Home Health Agency Business Is Worth

Free exit score, valuation range, and personalized action plan — 5 minutes.

Get Free Score

Frequently Asked Questions

How long does it take to sell a home health agency?

Most home health agency sales take 12–24 months from the decision to sell to closing, when you include preparation time. The transaction itself — from finding a buyer to closing — typically takes 6–12 months. The CMS change-of-ownership (CHOW) process adds 60–180 days depending on whether it's an asset or stock sale and how quickly CMS and your state Medicaid office process the enrollment transfer. Sellers who start preparing early — cleaning up financials, resolving compliance issues, and documenting operations — consistently achieve better prices and faster closes than those who go to market unprepared.

What is my home health agency worth?

Home health agencies in the $1M–$5M revenue range typically sell for 3.5x–6x trailing twelve-month EBITDA, with healthy agencies with strong margins, clean compliance history, and 50+ active patients landing in the 5x–6x range. Agencies with open billing audits, heavy owner dependency, or low star ratings tend to price at 3.5x–4.5x. EBITDA margins in this industry typically run 10–20%, so a $2M revenue agency generating $300K in normalized EBITDA might be worth $1.05M–$1.8M. Your payor mix, CMS star ratings, management team depth, and referral source diversification all influence where in that range you land.

What is the CHOW process and how does it affect my sale?

The CMS change-of-ownership process is the federal mechanism by which Medicare billing privileges are transferred from your agency to a new owner. In an asset sale, the buyer typically must re-enroll as a new Medicare provider, which can take 60–180 days and creates a reimbursement gap. In a stock sale, Medicare certification may transfer with the legal entity, but the buyer assumes all historical compliance liability. Most deals account for CHOW by using a holdback, seller earnout, or management agreement during the transition period. Working with a healthcare M&A attorney before you sign a letter of intent is essential to structuring these provisions correctly.

Will a buyer require a billing compliance audit before closing?

Yes — virtually every sophisticated buyer of a Medicare-certified home health agency will conduct a billing compliance audit as part of due diligence. This audit reviews your claims history, denial rates, overpayment exposure, OASIS coding accuracy, and documentation practices. If the buyer's auditors find problems you haven't disclosed, they will use those findings to renegotiate price or walk away. The best practice is to commission your own third-party compliance audit 12–18 months before going to market, remediate any findings, and be prepared to share the results proactively. Sellers who do this consistently experience fewer surprises and stronger offers.

Can I sell my home health agency if I am the only clinical leader?

You can sell it, but your owner dependency will significantly affect your multiple and deal structure. Buyers — especially PE-backed platforms and SBA-financed individual buyers — need confidence the agency can operate after you leave. If you are the director of nursing, the primary referral relationship manager, and the person running billing, buyers will either discount their offer by 20–30%, require an extended transition or employment agreement of 1–3 years, or structure a larger portion of your proceeds as an earnout tied to post-close performance. The best thing you can do 12–18 months before selling is hire and develop a clinical and administrative team that can run the agency without you.

What do PE-backed roll-up buyers look for in a home health agency acquisition?

PE-backed platforms executing geographic roll-ups are primarily looking for: active Medicare and Medicaid certification with a clean compliance history, a minimum of 50–100 active patients with a diversified payor mix, an EBITDA margin of at least 10–15%, a clinical and administrative team that does not require the seller to stay, strong CMS star ratings and low hospitalization rates, and referral relationships with hospitals or physician groups that can be maintained by new ownership. They typically pay at the higher end of the multiple range — 5x–6x — but they move quickly, conduct rigorous due diligence, and expect sellers to have clean, auditable financials and compliance documentation ready from day one.

Should I structure my sale as an asset purchase or stock sale?

For most home health agency sellers, buyers prefer an asset purchase because it allows them to acquire the business without assuming historical compliance liabilities — including any undiscovered billing overpayments or CMS audit exposure. However, a stock sale can be advantageous for sellers if it means Medicare certification transfers without a lengthy re-enrollment, reducing deal risk. The tradeoff is that buyers paying stock sale pricing typically demand indemnification provisions or escrow holdbacks to protect against inherited liabilities. The right answer depends on your compliance history, your state's Medicaid enrollment rules, and your negotiating position. A healthcare M&A attorney should guide this decision before you execute a letter of intent.

More Home Health Agency Seller Guides

More Exit Checklists

Start Your Free Exit Assessment

Get your Home Health Agency exit score, estimated valuation, and a step-by-step action plan — free, in 5 minutes.

Start Your Free Exit Assessment

Free forever · No broker needed · Takes 5 minutes